mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
0.026 |
0.6 |
mRNA |
MG-132 |
GDSC1000 |
pan-cancer |
AAC |
0.025 |
0.6 |
mRNA |
PD-0332991 |
CCLE |
pan-cancer |
AAC |
-0.025 |
0.6 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
BMS-509744 |
GDSC1000 |
pan-cancer |
AAC |
0.027 |
0.6 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
0.027 |
0.6 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |